logo image
search icon
Global Plasma Proteins Market

Plasma Proteins Market Size, Share & Trends Analysis Report By Product Type (Coagulation Factors, Immunoglobulin, Alpha-1 Proteinase Inhibitor, and Albumin), By Clinical Application, Region And Segment Forecasts, 2023-2031.

Report ID : 1098 | Published : 2023-09-27 | Pages: 180 | Format:

The Plasma Proteins Market Size is valued at 27820.0 Million in 2022 and is predicted to reach 56112.2 Million by the year 2031 at an 8.2 % CAGR during the forecast period for 2023-2031.

Plasma Proteins Market

It is expected to shwo a CAGR of 8.56% during a forecast period of 2022-2030. Plasma is defined as a part of blood, which is a clear, straw-colored fluid residue after red platelets, white blood cells, blood cells, and other cellular components got eliminated. Human blood consists of various proteins. A mixture of lipoproteins, simple proteins, glycoproteins, and other conjugated proteins are called plasma proteins. By replacing the deficient or missing proteins in plasma, Plasma protein therapies are used to treat the well-defined medical condition. Plasma protein therapeutics include biological medicines, which are either infused or injected to treat life-threatening, chronic and genetic diseases. This plasma protein plays a vital role in blood clotting and also provides immunity against diseases.

Increasing usage of the plasma protein derived medicines worldwide; the introduction of new plasma-derived therapies is the major driving factors of the global plasma protein market. The market is also driven by a host of other factors, including the rising prevalence of life-threatening diseases of immune or neurological systems and infectious diseases like Rabies, Tetanus, Hepatitis A&B, and varicella. On the contrary, there are a few restraints for the market, which include stringent government policies, issues pertaining to reimbursement, complexity in manufacturing biologics, which may limit the growth of the market. With the technological advancements, the process involving fractionating the protein from plasma has become high-cost saving and efficient, which is also supposed to boost the global plasma protein therapeutics market. With increasing awareness among people about blood donations and government initiatives, the plasma-derived medicine market is expected to grow in the coming years at a significant rate.

Market Segmentation

The global plasma protein market is segmented on the basis of product type, which is further divided into coagulation factors, immunoglobulin, alpha-1 proteinase inhibitor, and albumin. Based on application, plasma protein therapeutics is segmented into idiopathic thrombocytopenic purpura, secondary immunodeficiency, hemophilia, hereditary angioedema, primary immunodeficiency disorder, and other indications. Based on geographical region, the market assessment is divided into the regions of North America, Asia-Pacific, Europe, Latin America, and Middle-East & Africa.
North America stood as a developed market for plasma protein therapeutic and is going to see quick growth in the future. Europe was one of the leading regional markets, followed by North America, and is expected to show significant growth in the years to come. In Europe, plasma protein therapeutics products are considered non-prescription products that allow their widespread use. Growth in the Asia Pacific plasma protein therapeutics market was expected to be driven by the increasing awareness about blood donations. In the Middle East & Africa region, the market is likely to register a modest growth rate due to a lack of awareness. Latin America is known to be an important regional market and is expected to experience sensible growth over the forecast period. Thus, all the above-stated improvements are going to push the market growth in the future.
C1 esterase inhibitor (Ruconest), Human glucocerebrosidase (Elelyso), VEGFR Fc-fusion (Eylea), CTLA-4 Fc-fusion (Nulojix), Anti-IL-6 receptor (Actemra), Anti-CD30 (Adcetris) are some of the U.S FDA approved therapeutic proteins that are produced by using different protein engineering technologies.

Competitive Landscape

Some of The Key Players in The Plasma Proteins Market:

  • Baxter
  • BPL Group
  • CSL Behring
  • Grifols
  • Japan Red Cross
  • Kedrion
  • LFB Group
  • Octapharma
  • Sanquin
  • Shanghai Blood Institute
  • Other Prominent Players

The Plasma Proteins Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 27820.0 Million

Revenue Forecast In 2031

USD 56112.2 Million

Growth Rate CAGR

CAGR of 8.2 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product Type, By Clinical Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Octapharma, LFB Group, Grifols, Baxter, CSL limited, Telecris, Kedrion, and Chengdu Inst; Japan Red Cross, BPL Group, Shanghai Blood Institute, Sanquin, and Others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Plasma Proteins Market Snapshot

Chapter 4. Global Plasma Proteins Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Product Types Estimates & Trend Analysis

5.1. By Product Types & Market Share, 2022 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Product Types:

5.2.1. Coagulation factors

5.2.2. Immunoglobulin

5.2.3. Alpha-1 proteinase inhibitor

5.2.4. Albumin

Chapter 6. Market Segmentation 2: By Clinical Application Estimates & Trend Analysis

6.1. By Clinical Application & Market Share, 2022& 2030

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Clinical Application:

6.2.1. Hemophilia

6.2.2. Idiopathic Thrombocytopenic Purpura

6.2.3. Secondary Immunodeficiency

6.2.4. Hereditary Angioedema

6.2.5. Primary Immunodeficiency Disorder

Chapter 7. Plasma Proteins Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Product Types, 2022 - 2030

7.1.2. North America Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Clinical Application, 2022 - 2030

7.1.3. North America Plasma Proteins Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030

7.2. Europe

7.2.1. Europe Plasma Proteins Market revenue (US$ Million) By Product Types, 2022 - 2030

7.2.2. Europe Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Clinical Application, 2022 - 2030

7.2.3. Europe Plasma Proteins Market revenue (US$ Million) by country, 2022 - 2030

7.3. Asia Pacific

7.3.1. Asia Pacific Plasma Proteins Market revenue (US$ Million) By Product Types, 2022 - 2030

7.3.2. Asia Pacific Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Clinical Application, 2022 - 2030

7.3.3. Asia Pacific Plasma Proteins Market revenue (US$ Million) by country, 2022 - 2030

7.4. Latin America

7.4.1. Latin America Plasma Proteins Market revenue (US$ Million) By Product Types, (US$ Million)

7.4.2. Latin America Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Clinical Application, 2022 - 2030

7.4.3. Latin America Plasma Proteins Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

7.5. Middle East & Africa

7.5.1. Middle East & Africa Plasma Proteins Market revenue (US$ Million) By Product Types, (US$ Million)

7.5.2. Middle East & Africa Plasma Proteins Market revenue (US$ Million) estimates and forecasts By Clinical Application, 2022 - 2030

7.5.3. Middle East & Africa Plasma Proteins Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles

8.2.1. Baxter

8.2.2. CSL Behring

8.2.3. Grifols

8.2.4. Kedrion

8.2.5. LFB Group

8.2.6. Octapharma

8.2.7. Sanquin

8.2.8. Other Prominent Player

Global Plasma Proteins Market Segmentation

Global Plasma Proteins Market based on Product Type

  • Coagulation factors
  • Immunoglobulin
  • Alpha-1 proteinase inhibitor
  • Albumin

Plasma Proteins Market

Global Plasma Proteins Market based on Clinical Application

  • Hemophilia
  • Idiopathic Thrombocytopenic Purpura
  • Secondary Immunodeficiency
  • Hereditary Angioedema
  • Primary Immunodeficiency Disorder

Global Plasma Proteins Market Based on Geographical Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • South Korea
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Plasma Proteins Market Size?

The Plasma Proteins Market is expected to grow at an 8.2 % CAGR during the forecast period for 2023-2031.

Octapharma, LFB Group, Grifols, Baxter, CSL limited, Telecris, Kedrion, and Chengdu Inst; Japan Red Cross, BPL Group, Shanghai Blood Institute, Sanqui

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach